| Product Code: ETC7749927 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Targeted Cancer Therapy Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Targeted Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Targeted Cancer Therapy Market - Industry Life Cycle |
3.4 Japan Targeted Cancer Therapy Market - Porter's Five Forces |
3.5 Japan Targeted Cancer Therapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Targeted Cancer Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Targeted Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer cases in Japan |
4.2.2 Increasing awareness and adoption of targeted cancer therapy |
4.2.3 Technological advancements in precision medicine |
4.2.4 Supportive government initiatives and funding for cancer research |
4.2.5 Rising demand for personalized medicine in oncology |
4.3 Market Restraints |
4.3.1 High cost associated with targeted cancer therapy |
4.3.2 Stringent regulatory requirements and lengthy approval processes |
4.3.3 Limited accessibility to advanced targeted therapy options in certain regions |
4.3.4 Potential resistance to change in traditional cancer treatment approaches |
4.3.5 Concerns regarding the long-term efficacy and safety of targeted therapies |
5 Japan Targeted Cancer Therapy Market Trends |
6 Japan Targeted Cancer Therapy Market, By Types |
6.1 Japan Targeted Cancer Therapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Targeted Cancer Therapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Targeted Cancer Therapy Market Revenues & Volume, By Tumor Antigens As Targets of Antibodies, 2021- 2031F |
6.1.4 Japan Targeted Cancer Therapy Market Revenues & Volume, By Development of Antibodies for Clinical Purposes, 2021- 2031F |
6.1.5 Japan Targeted Cancer Therapy Market Revenues & Volume, By Complement Dependent Cytotoxicity (CDC), 2021- 2031F |
6.1.6 Japan Targeted Cancer Therapy Market Revenues & Volume, By Signal Transduction Changes, 2021- 2031F |
6.2 Japan Targeted Cancer Therapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Targeted Cancer Therapy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Japan Targeted Cancer Therapy Market Revenues & Volume, By Clinic, 2021- 2031F |
7 Japan Targeted Cancer Therapy Market Import-Export Trade Statistics |
7.1 Japan Targeted Cancer Therapy Market Export to Major Countries |
7.2 Japan Targeted Cancer Therapy Market Imports from Major Countries |
8 Japan Targeted Cancer Therapy Market Key Performance Indicators |
8.1 Patient survival rate post targeted cancer therapy treatment |
8.2 Rate of adoption of targeted therapies by healthcare facilities |
8.3 Number of clinical trials and research studies related to targeted cancer therapy |
8.4 Patient satisfaction and quality of life improvements post-treatment |
8.5 Investment and funding trends in precision oncology research and development |
9 Japan Targeted Cancer Therapy Market - Opportunity Assessment |
9.1 Japan Targeted Cancer Therapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Targeted Cancer Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Targeted Cancer Therapy Market - Competitive Landscape |
10.1 Japan Targeted Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 Japan Targeted Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here